Seifritz E
Department of Adult Psychiatry and Psychotherapy, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
PreprintKetamine
Esketamine for treatment-resistant depression: Comparing two maintenance schedules in an observational real-world study
ArticleKetamine
Ketamine-Assisted Psychotherapy for Posttraumatic Stress Disorder: A Systematic Review and Individual Participant Data Meta-Analysis of Predictors of Treatment Effects.
ArticlePsilocybin
Real-World Psilocybin Therapy for Treatment-Resistant Depression: A Retrospective Observational Study.
ArticleMDMA
Memory deficits of MDMA users are linked to cortical thinning related to 5-HT receptor densities.
PreprintPsilocybin
Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study
ArticleKetamine
The role of frontal EEG in predicting clinical response of major depressive disorder to intranasal ketamine and esketamine.
ArticlePsilocybin
Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat.
PreprintPsilocybin
Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of <i>N,N</i>-Dimethyltryptamine and Harmine in a Meditation Retreat
ArticlePsilocybin
Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.
ArticleAyahuasca
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.
ArticleAyahuasca
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.
ArticleKetamine
Combined Effects of Nasal Ketamine and Trauma-Focused Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder: A Pilot Case Series.
ArticlePsilocybin
The influence of psilocybin on subconscious and conscious emotional learning.
ArticleKetamine
Ketamine induces multiple individually distinct whole-brain functional connectivity signatures.
ArticlePsilocybin
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.
ArticleAyahuasca
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.
ArticlePsilocybin
Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.
ArticlePsilocybin
TMS-EEG and resting-state EEG applied to altered states of consciousness: oscillations, complexity, and phenomenology.
ArticlePsilocybin
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.
ArticlePsilocybin
Psychedelics in the treatment of unipolar and bipolar depression.
ArticleLSD
LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.
ArticleKetamine